Please ensure Javascript is enabled for purposes of website accessibility

Why Teladoc Stock Dropped Today

By Joe Tenebruso – Apr 30, 2020 at 4:44PM

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Some investors are taking profits, but this long-term growth story is still in its early innings.

What happened

Shares of Teladoc Health (TDOC -3.54%) fell 6% on Thursday, following the release of the telehealth leader's first-quarter results.

So what

Teladoc's revenue surged by 41% year over year, to $180.8 million. The gains were driven by a 29% rise in subscription revenue and a 93% surge in visit-fee revenue.

Notably, Teladoc saw its total paid membership in the U.S soar 60.8% to 43 million. People are also using its telehealth services more often; the total number of visits to its platform jumped 92%.

A person is hooked up to a blood pressure measuring device while having a video conference with a doctor.

More people are using Teladoc's telehealth services, which facilitate healthcare consultations via the internet. Image source: Getty Images.

"In the first quarter of 2020 alone, Teladoc Health delivered 2 million medical visits to people around the world, while simultaneously expanding access to millions of new members," CEO Jason Gorevic said in a press release. "As our clients and consumers have turned to us during these unprecedented times, our proven ability to meet their needs has elevated our global leadership role and accelerated our impact on the healthcare system overall."

Investors, however, appear to be focusing on Teladoc's net loss per share, which, at $0.40, was larger than the $0.35 loss Wall Street was expecting.  

Now what 

After Teladoc's incredible gains in 2020 (its stock had more than doubled prior to its earnings release), it's understandable that some investors decided to take some profits off the table. But long-term investors might want to hold on to their shares, as Teladoc is still early in its growth cycle.

Joe Tenebruso has no position in any of the stocks mentioned. The Motley Fool owns shares of and recommends Teladoc Health. The Motley Fool has a disclosure policy.

Invest Smarter with The Motley Fool

Join Over 1 Million Premium Members Receiving…

  • New Stock Picks Each Month
  • Detailed Analysis of Companies
  • Model Portfolios
  • Live Streaming During Market Hours
  • And Much More
Get Started Now

Stocks Mentioned

Teladoc Health, Inc. Stock Quote
Teladoc Health, Inc.
$26.97 (-3.54%) $0.99

*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.

Related Articles

Motley Fool Returns

Motley Fool Stock Advisor

Market-beating stocks from our award-winning analyst team.

Stock Advisor Returns
S&P 500 Returns

Calculated by average return of all stock recommendations since inception of the Stock Advisor service in February of 2002. Returns as of 09/24/2022.

Discounted offers are only available to new members. Stock Advisor list price is $199 per year.

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.